Skip to Content

RE 212 (Re-drylex Jr 4-10-1.25 MG)

Generic Name: chlorpheniramine/methscopolamine/phenylephrine

Pill imprint RE 212 has been identified as Re-drylex Jr 4-10-1.25 MG.

Re-Drylex Jr is used in the treatment of rhinitis; nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Re-Drylex Jr 4-10-1.25 MG is not a controlled substance under the Controlled Substance Act (CSA).

Re-drylex Jr
Generic Name:
chlorpheniramine/methscopolamine/phenylephrine
Imprint:
RE 212
Strength:
4-10-1.25 MG
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
RIVER'S EDGE PHARMACEUTICALS

More info Print Imprint Search

More about Re-Drylex Jr (chlorpheniramine / methscopolamine / phenylephrine)

Consumer resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide